Press Releases Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
6.11 ^USD	-9.48%		-12.21%	+117.44%

09/05	Black Diamond Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
11/04	Black Diamond Therapeutics, Inc. Announces Board and Committee Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05	GL
Black Diamond: Q1 Earnings Snapshot	09/05	AQ
Black Diamond Therapeutics : Reports First Quarter 2024 Financial Results and Provides Corporate Update - Form 8-K	09/05	PU
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	25/04	GL
Black Diamond Therapeutics Announces Changes to Board of Directors	11/04	GL
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08/04	GL
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08/04	AQ
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	03/04	GL
Black Diamond: Q4 Earnings Snapshot	12/03	AQ
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12/03	GL
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12/03	AQ
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024	06/03	GL
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28/02	GL
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28/02	AQ
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04/01	GL
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04/01	AQ
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	13/12	GL
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	07/11	GL
Black Diamond Therapeutics : November 2023 Corporate Presentation	06/11	PU
Black Diamond: Q3 Earnings Snapshot	06/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Press Releases

Filters